Prostate Cancer - Results from #19880

Effect of histological inflammation on total and free serum prostate-specific antigen values in patients without clinically detectable prostate cancer - Abstract September 25, 2014

Resource utilization and use of life-extending therapies and corticosteroids in prostate cancer patients with corticosteroid-sensitive comorbidities - Abstract September 25, 2014

Enzalutamide in European and North American men participating in the AFFIRM trial - Abstract September 25, 2014

Comparison of NaF and FDG PET/CT for assessment of treatment response in castration-resistant prostate cancers with osseous metastases - Abstract September 25, 2014

Perioperative changes in pro and anticoagulant factors in prostate cancer patients undergoing laparoscopic and robotic radical prostatectomy with different anaesthetic techniques - Abstract September 25, 2014

Survival disparities between Māori and non-Māori men with prostate cancer in New Zealand - Abstract September 25, 2014

Prostate pointers and pitfalls: The 10 most prevalent problems in prostate biopsy interpretation - Abstract September 24, 2014

Utility of an initial adaptive bladder volume control with ultrasonography for proton-beam irradiation for prostate cancer - Abstract September 24, 2014

Maximum tumor diameter adjusted to the risk profile predicts biochemical recurrence after radical prostatectomy - Abstract September 24, 2014

How to minimize lymphoceles and treat clinically symptomatic lymphoceles after radical prostatectomy - Abstract September 24, 2014

Affecting African American men's prostate cancer screening decision-making through a mobile tablet-mediated intervention - Abstract September 24, 2014

Prevention of erectile dysfunction after radiotherapy for prostate cancer - Abstract September 24, 2014

Clinical performance of Prostate Health Index (PHI) for prediction of prostate cancer in obese men: Data from a multicenter European prospective study, PROMEtheuS project - Abstract September 24, 2014

Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: Efficacy and predictive parameters in a large single center cohort - Abstract September 24, 2014

Implementation of PSA-based active surveillance in prostate cancer - Abstract September 24, 2014

Screening for prostate cancer in the US? Reduce the harms and keep the benefit - Abstract September 24, 2014

Prostate cancer mortality outcomes and patterns of primary treatment for Aboriginal men in New South Wales, Australia - Abstract September 24, 2014

Association of androgen deprivation therapy with excess cardiac-specific mortality in men with prostate cancer - Abstract September 24, 2014

Multiparametric MRI in biopsy guidance for prostate cancer: Fusion-guided - Abstract September 24, 2014

Symptomatic and incidental venous thromboembolic disease are both associated with mortality in patients with prostate cancer - Abstract September 24, 2014

Page 995 of 1447